Huntington Disease Ultrasound Trial, Fujian Medical University
Summary
Fujian Medical University registered a Phase 1/2 clinical trial (NCT07513844) on ClinicalTrials.gov investigating low-intensity ultrasound as a treatment for Huntington disease. The trial will assess safety and preliminary efficacy parameters in patients with the neurodegenerative condition. ClinicalTrials.gov serves as the primary public registry for clinical research conducted under FDA oversight.
What changed
A new clinical trial registration has been added to the ClinicalTrials.gov database for a Huntington disease ultrasound study sponsored by Fujian Medical University. The registration provides standard trial metadata including study design, eligibility criteria, outcome measures, and investigator information.
Affected parties including clinical investigators, healthcare providers, and medical device manufacturers should note this trial as a potential reference for emerging Huntington disease therapeutic approaches. The trial registration demonstrates increasing interest in neuromodulation techniques for neurodegenerative disorders.
What to do next
- Monitor for updates
Source document (simplified)
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.